[The sickness impact profile; results of an evaluation study of the Dutch version].
[The sickness impact profile; results of an evaluation study of the Dutch version].
复制标题
[疾病影响概况；
DOI：
--
复制
发表时间：
1990
期刊：
影响因子：
--
通讯作者：
D. Ra
中科院分区：
文献类型：
--
作者：
Jacobs Hm;A. Luttik;Touw Fw;D. Ra
美国的测斜仪，疾病影响轮廓(SIP)，在荷兰得到了验证。SIP是一份包含136条陈述的标准化清单，旨在测量由于疾病导致的日常活动中行为的变化，并可在临床研究中用作结果的衡量标准。验证研究的三个必要阶段被执行：转换、为声明分配权重因子以及在荷兰和美国开放人群中比较SIP测量。研究结果表明，有一个好的荷兰版的SIP，分配给荷兰版和美国版声明的权重因子之间存在很强的相关性，两国开放人口的SIP分数是一致的。荷兰开放人群的研究结果可作为其他研究的参考价值。
The U.S. clinimetric instrument, the sickness impact profile (SIP), was validated for The Netherlands. The SIP is a standardized list of 136 statements aimed at measuring changes of conduct in everyday activities due to sickness, and may be used as a measure of outcome in clinical studies. Three necessary stages of a validation study were performed: translation, assignment of weighing factors to the statements and comparison of SIP measurements in a Dutch and an U.S. open population. The findings were that a good Dutch version of the SIP is available, that there is a strong correlation between the weighing factors assigned to the statements of the Dutch and of the U.S. version, and that the SIP scores of open populations of the two countries are in agreement. The findings for the Dutch open population may be used as reference values in other studies.